Chorionic gonadotrophin

From Ganfyd

Jump to: navigation, search

Heterodimer of glycoprotein hormones alpha chain and choriogonadotropin subunit beta. Hormone produced by placental tissue and certain tumours. Its detection is the basis of the pregnancy test, but it is also used in monitoring trophoblastic disease and germ cell tumours, e.g. teratomas and certain testicular tumours, so raised levels are not always due to pregnancy.

Post-translational modification means it can be detected as a regular form, a hyperglycosylated form and as the free β-subunit of the hyperglycosylated form. The regular form is produced by placental syncytiotrophoblasts and maintains the myometrium and the placenta blood supply via the decidual spiral arteries. The hyperglycosylated form is produced by the cytotrophoblast and appears to function in an autocrine manner to promote 'invasion' of the placenta.[1] This same hyperglycosylated form is raised in trophoblastic disease as is the free β-subunit of the hyperglycosylated form.[2]

Variants of hCG that have missing residues in the peptide sequence are also recognised ('nicked' hCG) and may account for differences in assays.[3][4]

Contents

Clinical Applications

hCG in Pregnancy Testing

  • HCG is produced once the embryo is implanted (6-12 days).[5] Most commercial urine kits should be able to detect pregnancy as early as first missed period (i.e. 3-4 weeks). The threshold value for detection is ~25 mU/l.
  • HCG falls after the first few weeks of pregnancy as the hormones required to sustain pregnancy are taken over by the placenta. By 20 weeks false negatives are possible. However, in most women, a pregnancy test is not the most useful way of confirming or excluding a 20 week pregnancy. Sustained levels of hCG after week 14 may be seen in gestational trophoblastic disease.
  • Remains elevated after miscarriage or termination for some days (half-life thought to be about 24-48 hours).
  • Rarely, mutations in the hCG may result in negative pregnancy tests.

The very first assays for hCG detected the whole dimer, but were sometimes poor at distinguishing between hCG and the structurally similar luteinising hormone (LH), with which it shares the same α-chain. In 1973, an assay specific to the beta sub-unit was developed,[6] though this method has now been superceded by more modern assays that detect the whole unit. Despite this, pregnancy testing is still commonly associated with detection of the β-subunit and 'β-hCG' is often used when it is really the hCG dimer that is intended to be measured.

hCG in Trophoblastic Disease

False positives are rare, but may result from heterophile antibodies. Assay of 'β-hCG' itself, as opposed to the whole hCG molecule, may be relevant in trophoblastic disease.
Anecbubble.pngThe overreliance on a falsely raised hCG level using an assay from Abbott Laboratories resulted in the then 22 year old Jennifer Rufer, an American, having a hysterectomy and lung surgery. Had her doctors tested her urine, it would have tested negative.
{{{2}}}


References

Personal tools